- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04385576
Taiwan "Aerosol Box" Versus UMMC "Intubation Box"
Taiwan "Aerosol Box" Versus UMMC "Intubation Box" : Clinical Evaluation of the "Intubation Box" for Ease of Intubation
Study Overview
Status
Intervention / Treatment
Detailed Description
Background:
Intubation is classified as an aerosol-generating procedure (AGP). Intubation in a confirmed COVID-19 patient with a high viral load poses a high risk of exposure to health care workers (HCW). To reduce this risk, the HCW and their assistants are advised to don full personnel protective equipment (PPE) with a powered air purifying respiratory (PAPR) during intubation. In view of this concern, this procedure is highly recommended to be done in a negative pressure room to control the spread of aerosolizing particles in the room. A first-pass success in intubation is also crucial to minimize the risk of infection to health care workers involved.
Introduction :
An Aerosol Box (from here on known as Box A) was recently designed by Dr. Lai Hsien Yung from Taiwan which adds extra protection to the intubator and the surrounding environment. The Aerosol Box is a transparent box made of acrylic or transparent polycarbonate sheet, designed with an opening on one side allowing it to fit over the patient's chest and neck, while the opposing side has two holes through which the intubator can insert their hands through. It was shown that this barrier enclosure during intubation protects the laryngoscopist. A recent study simulated a patient with a cough during intubation with and without the Aerosol Box. With the box, it was demonstrated that the simulated cough resulted in contamination of only the inner surface of the box, the laryngoscopist's gloves and gowned forearms. Examination of the laryngoscopist and the room with ultraviolet light after the simulated cough also showed no macroscopic contamination outside the box. In contrast, intubation without the box demonstrated that the laryngoscopist's gown, gloves, face mask, eye shield, hair, neck, ears, and shoes were all contaminated.
Feedbacks from our colleagues stated that intubation with Box A is slightly difficult and may cause delay in intubation. Canelli et al also concluded this observation. The investigators, therefore, innovated the design of Box A to facilitate the laryngoscopist, known as the UMMC Intubation Box (from here on known as Box B).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Selangor
-
Kuala Lumpur, Selangor, Malaysia, 59100
- Recruiting
- University Malaya Medical Centre
-
Contact:
- SHAIRIL R RUSLAN, MAnaes(UM)
- Phone Number: 0123291074
- Email: shairil@ummc.edu.my
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- anaesthetists with more than 5 years of clinical experience AND more than 20 successful intubations using a videolaryngoscope
Exclusion Criteria:
- anaesthetists with less than 5 years of clinical experience AND/OR less than 20 successful intubations using a videolaryngoscope
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Aerosol Box
Intubation using the Taiwan model Aerosol Box to assess the duration of time needed for successful endotracheal intubation of an airway manikin.
|
Usage of an Intubation Box to minimize intubator and environment contamination during intubation and extubation.
Time taken for first-pass success if also expected to be reduced with the usage of the Intubation Box.
Usage of an Intubation Box to minimize intubator and environment contamination during intubation and extubation.
Time taken for first-pass success if also expected to be reduced with the usage of the Intubation Box.
|
|
Active Comparator: Intubation Box
Intubation using the UMMC model Intubation Box to assess the duration of time needed for successful endotracheal intubation of an airway manikin.
|
Usage of an Intubation Box to minimize intubator and environment contamination during intubation and extubation.
Time taken for first-pass success if also expected to be reduced with the usage of the Intubation Box.
Usage of an Intubation Box to minimize intubator and environment contamination during intubation and extubation.
Time taken for first-pass success if also expected to be reduced with the usage of the Intubation Box.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to successful intubation
Time Frame: 10 minutes
|
The interval from insertion of the laryngoscope blade into the mouth to inflation of the tracheal tube cuff
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of intubation attempts
Time Frame: 10 minutes
|
Number of attempts taken to successfully intubate the airway manikin
|
10 minutes
|
|
Evaluation of the intubator's experience using both boxes
Time Frame: 10 minutes
|
Evaluation of the intubator's experience using both boxes using a questionnaire based on the ISO9421-11 standard, that is effectiveness, efficiency and satisfaction.
|
10 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: INA I SHARIFFUDDIN, MAnaes, University of Malaya
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020410-8498
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
RSUP PersahabatanCompletedPost COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID Syndrome Long CovidIndonesia
Clinical Trials on Aerosol Box
-
Universiti Kebangsaan Malaysia Medical CentreCompleted
-
Derince Training and Research HospitalCompletedCOVID-19 | Intubation, IntratrachealTurkey
-
KidSIM Simulation ProgramCanadian Institutes of Health Research (CIHR)RecruitingCOVID-19 | Cardiac Arrest | CoronavirusUnited States, Canada
-
Express CollaborativeCanadian Institutes of Health Research (CIHR); International Network for Simulation-based...CompletedCovid19 | Coronavirus | COVID-19 Acute Respiratory Distress SyndromeUnited States, Canada
-
University of MalayaCompleted
-
Çanakkale Onsekiz Mart UniversityCompleted
-
Second Affiliated Hospital of Soochow UniversityRecruitingParkinson Disease | Sleep Disorder | Circadian Rhythm DisordersChina
-
The Third Xiangya Hospital of Central South UniversityUnknownAtrial Fibrillation | Atrial Remodeling
-
University of ManitobaCanadian Paediatric Society; Manitoba Health, Seniors and Active LivingCompletedSudden Infant DeathCanada
-
Columbia UniversityHelen Hayes HospitalTerminated